Category: Pharmaceutical Injuries

The American Association for Justice (AAJ) has invited attorney Ellen Presby of the nationally recognized Nemeroff Law Firm to speak at the organization’s Plaintiff-Only GranuFlo and Dialysis Products Seminar in New York City on Dec. 12, 2013. The seminar will offer legal developments, industry updates and trial techniques for cases involving the most widely-prescribed dry acid product in the dialysis industry today.

Presby, a trial attorney with Dallas-based Nemeroff Law Firm, was asked to speak during the Medical and Scientific Overview of GranuFlo Cases. The session will provide a generic overview of the process and mechanics of dialysis machines, an understanding of the science and chemistry of GranuFlo and the negative impacts experienced by patients.

“It’s essential for attorneys to understand the science behind these cases,” Presby said. “I’m honored to have the opportunity to share my knowledge and experience with this type of litigation.”

With nearly three decades of trial experience, Presby is a sought-after speaker and will also be moderating a portion of the upcoming AAJ 2014 Winter Convention. She holds multiple legal victories against major corporations, including a role in a $1.275 billion pharmaceutical class action settlement, and was recently appointed to the plaintiff’s steering committee for a major multidistrict pharmaceutical litigation. She specializes in personal injury and product liability cases and stands at the cutting edge of pharmaceutical law and trial techniques.

Presby has been listed as one of National Trial Lawyers Top 100 Lawyers from 2007 to 2012, a Texas Super Lawyer every year since 2003 and was named one of the top 50 female lawyers in Texas by Law & Politics Media and Texas Monthly magazine in 2004. She has served as Co- Chair of the State Bar of Texas Grievance Committee, and on the Boards of the Texas Trial Lawyers Association, the Public Justice Foundation, and the Dallas Chapter of the American Board of Trial Advocates.

Late last month – on Tuesday, October 21 st – Johnson & Johnson’s Janssen unit announced a recall of the popular blood-thinner medication Xarelto (rivaroxaban). According to officials from Janssen, 13,500 bottles of Xarelto are being recalled after microbial contamination was found in a sample.

The U.S. Food and Drug Administration (FDA) also released an Enforcement Report confirming that the recall was prompted by a Xarelto sample which tested positive for microbial contamination. The contaminated sample – which came from a production plant in Puerto Rico – was tested after a customer filed a complaint.

Janssen, which has already faced a number of complaints involving Xarelto, issued a nationwide voluntary recall shortly after discovering evidence of contamination. According to an official statement, Janssen made the decision to recall the entire lot of bottles manufactured at its Puerto Rico facility, even though contamination was found in only one sample bottle.

More Concerns About Xarelto
Xarelto’s contamination recall is only the latest concern about the popular pharmaceutical, which has been heavily scrutinized for associated adverse effects. In recent years, Xarelto has been linked to cases of injury, hospitalization, and death due to issues of uncontrolled bleeding. These adverse events include cases of internal bleeding, subdural hemorrhaging, and severe bleeding that cannot be stopped. Many victims and families have begun filing lawsuits for the harm and suffering they experienced after taking Xarelto.

Click here to find more information about Xarelto lawsuits.

Learn More About Xarelto Injuries & Your Rights
Nemeroff Law Firm has been dedicated to fighting on behalf of victims and families who’ve suffered preventable harm at the hands of Big Pharma. Our pharmaceutical injury attorneys are currently reviewing cases of victims who experienced adverse side effects – including uncontrolled bleeding that resulted in hospitalization or death – after taking Xarelto.

If you would like more information about filing a Xarelto lawsuit, your rights, and how Nemeroff Law Firm can help, contact our legal team today for a free case evaluation.

In the past several months, concerns over the risks and safety of Xarelto – a popular prescription blood thinner – have been on the rise. In many cases, patients who took Xarelto have reported incidents of severe and uncontrollable bleeding, some serious enough to require hospitalization. A number of injuries and deaths have been associated with the drug. Despite the increase in adverse events reported by consumers, researchers recently found that Xarelto prescriptions are rising.

According to a recent study from the Institute for Safe Medication Practices (ISMP), researchers have discovered that more physicians are choosing to prescribe Xarelto (rivaroxaban) over Pradaxa (dabigatran), another blood thinner which has been found to carry potentially harmful side effects.

The study noted that Xarelto prescriptions increased to roughly 1 million per quarter, with Pradaxa prescriptions declining since 2012. At the end of 2013, Xarelto prescriptions surpassed those for Pradaxa by approximately two to one. Although they have not yet informed doctors how to prevent or stop cases of uncontrollable bleeding, Xarelto’s manufacturers are exploring the possibility of expanding the drug’s use to treat patients with acute coronary syndrome (ACS)

Although Bayer and Johnson & Johnson’s Janssen Unit has profited immensely from Xarelto, the companies’ medication has led to many cases of injury and death. In turn, many victims and families have begun to assert their rights and pursue compensation for their damages by filing lawsuits.

You can learn more about Xarelto lawsuits on our website or by requesting a free consultation with a member of our legal team.

Earlier this month, the U.S. Judicial Panel on Multidistrict Litigation announced the consolidation of federal Xarelto lawsuits in the United States District Court for the Eastern District of Louisiana. The announcement, made on December 12, is considered a turning point in nationwide litigation involving the popular blood-thinner, which has been linked to a number of injuries and deaths. Judge Eldon E. Fallon will preside over the MDL proceedings.

Understanding Xarelto Injury Lawsuits
Xarelto is a blood-thinner medication manufactured by Bayer and Johnson & Johnson’s Janssen Unit. In recent years, Xarelto has been associated with cases of severe and uncontrollable bleeding, and is alleged to have caused instances of injury and death among patients.

If you or a family member has experienced harm after taking Xarelto, you may be able to pursue financial compensation for your losses by filing a lawsuit. With the consolidation of Xarelto lawsuits nationwide, more victims and families across the nation will now have the resources to hold Xarelto’s manufacturers liable for the harm they caused.

You or a loved one may be able to file a Xarelto lawsuit if you experienced any of the following after taking the medication:

At the Nemeroff Law Firm, our attorneys have long advocated for victims and families who suffered preventable harm at the hands of powerful pharmaceutical companies. Throughout the years, we’ve been successful in protecting the rights of victims injured by dangerous drugs, and we’re prepared to put our experience and passion to work for you.

If you have questions about your rights, Xarelto lawsuits, and how our legal team can help you, contact Nemeroff Law Firm today for a FREE case review.

Late last month, Takeda Pharmaceutical Company – one of the largest pharmaceutical companies in the world – agreed to a $2.4 billion settlement to resolve thousands of lawsuits involving Actos. A popular prescription medication used to treat Type 2 diabetes, Actos has been associated with adverse side effects, including many cases of bladder cancer.

The settlement – reached Tuesday, April 28 th in Illinois Circuit Court of Cook County – will help provide compensation to thousands of victims who claim they were diagnosed with bladder cancer after taking Actos. As part of the settlement terms, Takeda has not admitted wrongdoing.

Takeda came under scrutiny after consumers began reporting bladder cancer diagnoses connected to Actos at alarming rates. After investigating claims, the U.S. Food and Drug Administration (FDA) released a statement that people who took Actos for more than one year faced a 40% increase in bladder cancer risks.

The substantial settlement speaks to the rights of consumers who are harmed by unsafe products and medications. If you have questions about your rights following an illness or injury you believe was caused by a pharmaceutical product, contact Nemeroff Law Firm for a free consultation.